Jaguar Health, Inc. (JAGX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Jaguar Health reported revenue of $11.5M, down 1.5% from $11.7M the year before. Net income was -$53.6M (a -465.4% net margin), or -$12059.25 per diluted share. Gross margin was 67.2% and operating margin was -398.8%. Operating activities generated -$23.7M of cash, leaving -$23.7M of free cash flow. At fiscal year end, Jaguar Health held $38.3M in total assets against $57.0M in total liabilities, including $968,000 of cash and equivalents.
Open the full interactive Jaguar Health financials → Quarterly statements, key ratios, valuation history and price charts.
Jaguar Health Key Stats
| Share Price | $4.16 |
|---|---|
| Market Cap | $224,396 |
| Revenue YoY Growth | -1.5% |
| 52-Week Range | $2.67 – $1,191.75 |
| Shares Outstanding | 53,941 (basic, 2026 Q2) |
Jaguar Health Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.4M | $4.3M | $12.0M | $9.8M | $11.7M | $11.5M |
| Cost of Goods Sold | $36.0M | $45.0M | $46.4M | $44.1M | $42.5M | $97,000 |
| Gross Profit | $6.1M | $2.0M | $9.9M | $7.7M | $9.7M | $7.7M |
| Operating Income | -$26.6M | -$40.7M | -$34.4M | -$34.3M | -$30.8M | -$45.9M |
| Pre-Tax Income | -$33.8M | -$52.6M | -$48.4M | -$41.9M | -$39.3M | -$54.0M |
| Income Tax | — | $0 | $0 | -$601,000 | $0 | $0 |
| Net Income | -$33.8M | -$52.6M | -$47.5M | -$41.3M | -$38.5M | -$53.6M |
| Diluted EPS | -$177187500.00 | -$69693750.00 | -$28491750.00 | -$1409625.00 | -$68612.25 | -$12059.25 |
Jaguar Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.1M | $3.2M | $20.3M | $1.2M |
| Net Income | -$9.5M | -$23.2M | $8.8M | -$12.7M |
| Diluted EPS | -$3297.00 | -$9.95 | -$204.00 | -$235.50 |
Jaguar Health Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.1M | — | $5.5M | $6.5M | $8.0M | $968,000 |
| Current Assets | $17.8M | $28.4M | $22.3M | $28.0M | $32.2M | $20.3M |
| Total Assets | $42.8M | $53.3M | $47.5M | $50.8M | $53.4M | $38.3M |
| Current Liabilities | $13.2M | $15.5M | $30.3M | $14.0M | $19.7M | $40.7M |
| Total Long-Term Debt | $16.2M | $28.2M | $33.6M | $35.9M | $35.5M | $42.5M |
| Total Liabilities | $25.6M | $41.4M | $48.8M | $45.9M | $44.4M | $57.0M |
| Shareholders' Equity | $17.2M | $11.9M | -$1.4M | $4.9M | $6.5M | -$18.7M |
Jaguar Health Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$15.3M | -$35.0M | -$33.1M | -$33.2M | -$29.4M | -$23.7M |
| Cash From Investing | -$7,000 | -$6,000 | -$1.7M | — | -$231,000 | -$41,000 |
| Cash From Financing | $19.5M | $43.9M | $23.2M | $34.2M | $31.2M | $23.7M |
| Free Cash Flow | -$15.3M | -$35.0M | -$33.2M | -$33.3M | -$29.4M | -$23.7M |
Figures from Jaguar Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Jaguar Health financials page for every line item.
Jaguar Health Company Profile
| Ticker | JAGX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | San Francisco, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001585608 |
Frequently Asked Questions
What was Jaguar Health's revenue in fiscal 2025?
Jaguar Health (JAGX) reported revenue of $11.5M for fiscal 2025.
What is Jaguar Health's annual revenue history?
Jaguar Health's annual revenue by fiscal year: 2020: $9.4M; 2021: $4.3M; 2022: $12.0M; 2023: $9.8M; 2024: $11.7M; 2025: $11.5M.
What was Jaguar Health's net income in fiscal 2025?
Jaguar Health reported net income of -$53.6M for fiscal 2025.
What was Jaguar Health's earnings per share (EPS) in fiscal 2025?
Jaguar Health's diluted EPS was -$12059.25 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Jaguar Health generate in fiscal 2025?
Jaguar Health generated -$23.7M of free cash flow in fiscal 2025.
What was Jaguar Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Jaguar Health reported revenue of $1.2M.
How much debt does Jaguar Health have?
Jaguar Health reported $42.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Jaguar Health are outstanding?
Jaguar Health reported a weighted average of 53,941 basic shares outstanding in 2026 Q2.
What is Jaguar Health's market cap?
Based on its latest closing price, Jaguar Health (JAGX) has a market capitalization of about $224,396.
When does Jaguar Health's fiscal year end?
Jaguar Health's fiscal year end, as registered with the SEC, is December 31.
Where is Jaguar Health headquartered?
Jaguar Health lists its business address in San Francisco, California in its SEC filings.